Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (HUM) is a leading health insurance provider specializing in government-sponsored healthcare programs and integrated wellness solutions. This dedicated news hub provides investors and industry professionals with timely updates on corporate developments, financial performance, and strategic initiatives shaping the healthcare sector.
Access authoritative information through verified press releases covering earnings announcements, Medicare Advantage plan expansions, Medicaid service updates, and partnerships in primary care innovation. Track regulatory filings related to prescription drug plans and pharmacy benefit management services critical to HUM's operations.
Key updates include insights into value-based care models, military health program (TRICARE) enhancements, and advancements in at-home healthcare services. All content is sourced directly from company communications to ensure accuracy for financial analysis and market trend evaluation.
Bookmark this page for streamlined access to HUM's latest operational milestones and healthcare industry leadership updates. Check regularly for objective reporting on developments impacting one of America's largest managed care organizations.
The Humana Foundation, the philanthropic arm of Humana (NYSE: HUM), has announced a $50,000 donation to support recovery efforts in Kentucky communities affected by recent severe storms and tornadoes. The donation will be directed to the Foundation for Appalachian Kentucky to address urgent needs in the aftermath of devastating storms that hit Laurel and Pulaski Counties on May 16, 2025, claiming at least 19 lives.
Additionally, Humana employees are participating in a dedicated giving campaign, with the Humana Foundation matching all donations. The funds will be distributed among various nonprofit organizations including the Team Kentucky Storm Relief Fund, United Way of Laurel County, Samaritan's Purse, and American Red Cross.
Humana Foundation CEO Tiffany Benjamin has been named to the inaugural TIME100 Philanthropy list, recognizing influential figures in philanthropy. Benjamin, who has led the foundation since 2022, is acknowledged for her work in advancing health equity and establishing innovative community health initiatives. Notable achievements include co-founding Face the Fight, a veteran suicide prevention initiative now supported by over 200 organizations. Benjamin also serves as Board Chair of the Center for Disaster Philanthropy and was previously recognized with the Outstanding Corporate Philanthropy Leadership Award and named among the 100 Most Influential Black Americans.
CenterWell Specialty Pharmacy, part of Humana (NYSE: HUM), has won the MMIT Specialty Pharmacy Patient Choice Award in the PBM/Payer category for the seventh time in eight years. The award recognizes customer satisfaction and patient care excellence based on the highest average net promoter scores from Zitter Insights surveys throughout 2024.
The pharmacy manages therapies for chronic and complex illnesses, offering clinical and educational services through its Centers of Excellence program. The program provides specialized treatment guidance for conditions including cancer, autoimmune disorders, neuromuscular disorders, pulmonary conditions, and rare diseases. Additionally, CenterWell assists patients in accessing financial assistance programs for specialty drugs.
Humana reported strong Q1 2025 financial results with GAAP earnings per share of $10.30 and Adjusted EPS of $11.58. The company's Insurance segment benefit ratio was 87.4%, aligning with previous expectations.
Key highlights:
- Affirmed full-year 2025 Adjusted EPS guidance of $16.25
- Revised GAAP EPS guidance to $14.68 from $15.88
- Maintained Insurance segment benefit ratio guidance of 90.1-90.5%
- Expects Medicare Advantage membership decline of 550,000
Notable developments include CenterWell Pharmacy being selected for NovoCare's weight loss medication fulfillment and a potential contract award in Illinois for dual-eligible special needs plans. The company's Q1 2025 consolidated pretax results reached $1,691 million GAAP and $1,893 million adjusted, showing significant improvement from Q1 2024.
Humana (NYSE: HUM) has announced its Board of Directors' declaration of a quarterly cash dividend of $0.885 per share. The dividend will be payable on July 25, 2025, to stockholders of record as of the close of business on June 27, 2025.
The company, which operates through Humana insurance services and CenterWell health care services, focuses on providing healthcare services to people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large.
The Humana Foundation, Humana Inc.'s philanthropic arm, has released a new report titled 'Strengthening Science and Community Impact Through Equitable Research Practices'. The report analyzes innovative research methods adopted by Foundation partners to promote health equity through community-engaged research.
The report highlights three key themes:
- Expanding Access and Opportunity: Research teams collaborate with local institutions to remove participation barriers
- Promoting Community Leadership: Community members are involved in multiple research stages through advisory boards and partnerships
- Respecting Human Dignity: Projects ensure fair treatment and transparency for all participants
According to Foundation leaders, community-engaged research strategies can enhance the implementation of health equity interventions and improve long-term effectiveness.
Humana Inc. (NYSE: HUM) has released its 2024 Impact Report, highlighting significant improvements in healthcare outcomes and community support. The report showcases achievements across four key areas: people, community, healthcare system, and environment.
Key highlights include:
- Medicare Advantage members experienced 11.6% fewer ER visits and 7.2% fewer hospital admissions under value-based care
- 423,690 Social Determinants of Health screenings conducted for Medicaid members, up 21% from 2023
- The Humana Foundation granted $14.2 million to over 30 organizations
- Interoperability infrastructure connects 750,000+ providers with 200 million shared clinical records across 5.6 million members
- Environmental initiatives resulted in 14.5% reduction in Scope 1 and 2 emissions
FAQ
What is the current stock price of Humana (HUM)?
What is the market cap of Humana (HUM)?
